Pharmaceutical

STAT+: Looking to retain billions, hospitals warn Medicare’s drug payment fix is ‘unlawful’

STAT+: Looking to retain billions, hospitals warn Medic...

Oct 26, 2023

Lobbyists claim Medicare would be violating federal law if it attempted to retro...

‘We’re absolutely making it too hard’: The complexity of adult immunization delivery hinders vaccine uptake

‘We’re absolutely making it too hard’: The complexity o...

Oct 26, 2023

The process of keeping track of which vaccines are recommended — and avoiding pa...

STAT+: Oncologists more likely to provide low-value care after receiving pharma money, study finds

STAT+: Oncologists more likely to provide low-value car...

Oct 26, 2023

Oncologists were more likely to provide low-value cancer care after receiving mo...

STAT+: Under-the-skin injection of Eisai’s Leqembi is as effective as IV infusion, new Alzheimer’s data show

STAT+: Under-the-skin injection of Eisai’s Leqembi is a...

Oct 26, 2023

A version of the Alzheimer’s disease drug Leqembi that can be given with a simpl...

Abemaciclib by Eli Lilly and Co for Neuroblastoma: Like...

Oct 25, 2023

Abemaciclib is under clinical development by Eli Lilly and Co and currently in P...

IMM-47 by ImmuneOnco Biopharmaceuticals (Shanghai) for ...

Oct 25, 2023

IMM-47 is under clinical development by ImmuneOnco Biopharmaceuticals (Shanghai)...

Alimta by Eli Lilly and Co for Triple-Negative Breast C...

Oct 25, 2023

Alimta is under clinical development by Eli Lilly and Co and currently in Phase ...

Trametinib dimethyl sulfoxide by Novartis for Relapsed ...

Oct 25, 2023

Trametinib dimethyl sulfoxide is under clinical development by Novartis and curr...

IMM-47 by ImmuneOnco Biopharmaceuticals (Shanghai) for ...

Oct 25, 2023

IMM-47 is under clinical development by ImmuneOnco Biopharmaceuticals (Shanghai)...

IMM-47 by ImmuneOnco Biopharmaceuticals (Shanghai) for ...

Oct 25, 2023

IMM-47 is under clinical development by ImmuneOnco Biopharmaceuticals (Shanghai)...

IMM-47 by ImmuneOnco Biopharmaceuticals (Shanghai) for ...

Oct 25, 2023

IMM-47 is under clinical development by ImmuneOnco Biopharmaceuticals (Shanghai)...

Surufatinib by Hutchison MediPharma for Neuroendocrine ...

Oct 25, 2023

Surufatinib is under clinical development by Hutchison MediPharma and currently ...

Ataluren by PTC Therapeutics for Duchenne Muscular Dyst...

Oct 25, 2023

Ataluren is under clinical development by PTC Therapeutics and currently in Phas...

SOF-10 by Chugai Pharmaceutical for Gastric Cancer: Lik...

Oct 25, 2023

SOF-10 is under clinical development by Chugai Pharmaceutical and currently in P...

STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax

STAT+: Pharmalittle: Pharma moves closer to a pricing d...

Oct 24, 2023

The pharmaceutical industry is close to a deal with the U.K. government over dru...

STAT+: Startup launches with $245 million for twice yearly asthma treatment

STAT+: Startup launches with $245 million for twice yea...

Oct 24, 2023

A new biotech has raised $245 million to test a new asthma medication that could...